Influenza A MP (58-66) Peptide GILGFVFTL | CAS 141368-69-6

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Influenza A MP (58-66) Peptide (GILGFVFTL)

US$178.10

Excluding tax and shipping fees

Limited stock

Description

About Influenza A MP (58-66) Peptide (GILGFVFTL)

Antigen Peptide Flu M1 58-66 is an immunodominant epitope derived from the Influenza A matrix protein (MP), ideal for immunological research and T-cell stimulation. This specific epitope, GILGFVFTL, is restricted by the HLA-A*02:01 allele and recognized as a key target in influenza immune responses. This Influenza MP (58-66) peptide is highly suitable for a range of immunological assays, particularly those targeting CD8+ T cells.

The Influenza A Matrix protein 1 Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Matrix protein 1 Peptide, H-GILGFVFTL-OH (Uniprot: P21429 aa: 58-66) from JPT is produced under strict quality control and quality management.

Influenza A MP (58-66) Peptide (GILGFVFTL) - Specifications

Peptide sequence: H-GILGFVFTL-OH

Amount: 1 mg

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Delivery Format: Freeze-dried in plastic vial

CAS: 141368-69-6

Application(s): T-cell immunity

Condition(s)/Topic(s): Influenza, Respiratory infection, Flu-like disease

Standard Delivery Time: approx. 10 days

Visit our webpage for more Peptide Tools to Study Influenza

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

Benefits of JPT's Influenza Antigen Peptides

Our JPT Peptide Technologies antigen peptides are manufactured with the highest quality standards, supported by long-standing expertise in peptide synthesis. Key advantages include:

Precision in Synthesis: All peptides are synthesized in Germany, with protocols designed to eliminate toxic contaminants and side products.

Customized Orders: Choose your peptide sequence, amount, and purity, with options for bulk orders and custom synthesis.

Stability and Quality Assurance: Each peptide undergoes HPLC-MS analysis for confirmation of purity and quality, and is provided as freeze-dried aliquots to enhance stability.

Clinical Research Ready: Proven record in clinical study applications.

Choose Your Custom Peptides for Influenza and More

At JPT, we support researchers by offering an extensive catalog of antigen peptides. Find your desired antigen peptide along with connected PepMix™ Peptide Pools and MHC Multimers. These tools enable efficient immune monitoring, T-cell epitope mapping, and development of immunotherapies and vaccines.

Why Choose Influenza A MP (58-66) for Immune Research?

The Flu M1 (58-66) peptide plays a critical role in immune research targeting the influenza virus. Leveraging this peptide in T-cell assays and other immunological applications enhances the accuracy of epitope mapping and immune response studies. Researchers can rely on JPT Peptide Technologies to supply high-quality peptides that meet rigorous standards for use in both pre-clinical and clinical research settings.

For more Peptide Tools to Study Influenza or to learn about our range of custom antigen peptides, visit our website. Let us assist you in selecting and synthesizing the right peptides for your research needs.

References

References for Influenza A MP (58-66) Peptide (GILGFVFTL)

References:Read References with Antigen Peptides

Documentation

Documentation for Influenza A MP (58-66) Peptide (GILGFVFTL)

Protocol_PepMix.pdf

Influenza-A-MP-58-66-Peptide-GILGFVFTL-2.pdf

Properties

Properties of Influenza A MP (58-66) Peptide (GILGFVFTL)

T-cell immunity

Antigen Peptides

Flu-like disease, Influenza, Respiratory infection

Freeze-dried in plastic vial

Influenza A

Matrix protein 1

Trial Grade: each peptide purified to > 90% (HPLC/MS)

Further Information to Influenza A MP (58-66) Peptide (GILGFVFTL)

Values

H-GILGFVFTL-OH

9mer peptide as TFA salt